Cargando…

Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations

Cancer patients may experience skin problems while undergoing chemotherapy and radiation therapy. Frequency of skin reactions may be influenced by skin pigmentation and psychological factors. A Symptom Inventory completed by 656 cancer patients nationwide before and after chemotherapy, radiation the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryan, J L, Bole, C, Hickok, J T, Figueroa-Moseley, C, Colman, L, Khanna, R C, Pentland, A P, Morrow, G R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359663/
https://www.ncbi.nlm.nih.gov/pubmed/17565347
http://dx.doi.org/10.1038/sj.bjc.6603842
_version_ 1782152887332241408
author Ryan, J L
Bole, C
Hickok, J T
Figueroa-Moseley, C
Colman, L
Khanna, R C
Pentland, A P
Morrow, G R
author_facet Ryan, J L
Bole, C
Hickok, J T
Figueroa-Moseley, C
Colman, L
Khanna, R C
Pentland, A P
Morrow, G R
author_sort Ryan, J L
collection PubMed
description Cancer patients may experience skin problems while undergoing chemotherapy and radiation therapy. Frequency of skin reactions may be influenced by skin pigmentation and psychological factors. A Symptom Inventory completed by 656 cancer patients nationwide before and after chemotherapy, radiation therapy, or chemotherapy plus radiation therapy was analysed to determine if treatment type, race (Black vs White), and pretreatment expectations influenced post-treatment skin reactions. Subsequent analysis of a local Symptom Inventory completed weekly for 5 weeks by 308 patients receiving radiation therapy examined severity of reported skin reactions. Significantly more patients receiving radiation therapy had stronger expectations of skin problems (62%) than patients receiving chemotherapy (40%, P=0.001) or chemotherapy plus radiation therapy (45%, P=0.003). Overall, expectations did not correlate with patient reported post-treatment skin problems in white (r=0.014, P=0.781) or black (r=0.021, P=0.936) patients. Although no significant difference was found between black and white patients in their pretreatment expectations of skin problems (P=0.32), black patients (10 out of 18, 56%) reported more skin problems than white patients (90 out of 393, 23%, P=0.001). Similarly, the local study showed that significantly more black patients (1 out of 5, 20%) reported severe skin reactions at the treatment site than white patients (12 out of 161, 8%). A direct correlation was observed between severity of skin problems and pain at the treatment site (r=0.541, P<0.001). Total radiation exposure did not significantly correlate with the report of skin problems at the treatment site for white or black patients. Overall, black patients reported more severe post-treatment skin problems than white patients. Our results suggest that symptom management for post-treatment skin reactions in cancer patients receiving radiation treatment could differ depending on their racial background.
format Text
id pubmed-2359663
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23596632009-09-10 Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations Ryan, J L Bole, C Hickok, J T Figueroa-Moseley, C Colman, L Khanna, R C Pentland, A P Morrow, G R Br J Cancer Clinical Study Cancer patients may experience skin problems while undergoing chemotherapy and radiation therapy. Frequency of skin reactions may be influenced by skin pigmentation and psychological factors. A Symptom Inventory completed by 656 cancer patients nationwide before and after chemotherapy, radiation therapy, or chemotherapy plus radiation therapy was analysed to determine if treatment type, race (Black vs White), and pretreatment expectations influenced post-treatment skin reactions. Subsequent analysis of a local Symptom Inventory completed weekly for 5 weeks by 308 patients receiving radiation therapy examined severity of reported skin reactions. Significantly more patients receiving radiation therapy had stronger expectations of skin problems (62%) than patients receiving chemotherapy (40%, P=0.001) or chemotherapy plus radiation therapy (45%, P=0.003). Overall, expectations did not correlate with patient reported post-treatment skin problems in white (r=0.014, P=0.781) or black (r=0.021, P=0.936) patients. Although no significant difference was found between black and white patients in their pretreatment expectations of skin problems (P=0.32), black patients (10 out of 18, 56%) reported more skin problems than white patients (90 out of 393, 23%, P=0.001). Similarly, the local study showed that significantly more black patients (1 out of 5, 20%) reported severe skin reactions at the treatment site than white patients (12 out of 161, 8%). A direct correlation was observed between severity of skin problems and pain at the treatment site (r=0.541, P<0.001). Total radiation exposure did not significantly correlate with the report of skin problems at the treatment site for white or black patients. Overall, black patients reported more severe post-treatment skin problems than white patients. Our results suggest that symptom management for post-treatment skin reactions in cancer patients receiving radiation treatment could differ depending on their racial background. Nature Publishing Group 2007-07-02 2007-06-12 /pmc/articles/PMC2359663/ /pubmed/17565347 http://dx.doi.org/10.1038/sj.bjc.6603842 Text en Copyright © 2007 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical Study
Ryan, J L
Bole, C
Hickok, J T
Figueroa-Moseley, C
Colman, L
Khanna, R C
Pentland, A P
Morrow, G R
Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations
title Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations
title_full Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations
title_fullStr Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations
title_full_unstemmed Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations
title_short Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations
title_sort post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359663/
https://www.ncbi.nlm.nih.gov/pubmed/17565347
http://dx.doi.org/10.1038/sj.bjc.6603842
work_keys_str_mv AT ryanjl posttreatmentskinreactionsreportedbycancerpatientsdifferbyracenotbytreatmentorexpectations
AT bolec posttreatmentskinreactionsreportedbycancerpatientsdifferbyracenotbytreatmentorexpectations
AT hickokjt posttreatmentskinreactionsreportedbycancerpatientsdifferbyracenotbytreatmentorexpectations
AT figueroamoseleyc posttreatmentskinreactionsreportedbycancerpatientsdifferbyracenotbytreatmentorexpectations
AT colmanl posttreatmentskinreactionsreportedbycancerpatientsdifferbyracenotbytreatmentorexpectations
AT khannarc posttreatmentskinreactionsreportedbycancerpatientsdifferbyracenotbytreatmentorexpectations
AT pentlandap posttreatmentskinreactionsreportedbycancerpatientsdifferbyracenotbytreatmentorexpectations
AT morrowgr posttreatmentskinreactionsreportedbycancerpatientsdifferbyracenotbytreatmentorexpectations